Lipgloss Break: rosacea

I can’t talk enough about how important it is to take care of your skin. Dry, oily, sensitive, no matter what your skin type, it’s important to research and talk to a skincare specialist about the right skincare regime for you.

Personally, I have dry, sensitive skin, and I’m also prone to rosacea. Yesterday I posted about Mirvaso (brimonidine) topical gel, 0.33%, a new topical gel specifically developed and indicated to treat the persistent facial redness of rosacea. Mirvaso is all about treating the redness, so you don’t have to conceal with makeup.

The Break Up with Your Makeup portal, which you can get to from yesterday’s post, includes information on skincare tips and the treatment for rosacea. You can also enter for a chance to win a trip to the Emmys! Enter by adding your email address into the portal and clicking ‘Submit.’

If you miss the window for entering the trip, don’t fret. Galderma, who also makes Cetaphil, has generously offered to give one lucky Lipgloss Break reader a Cetaphil Gift Basket! Enter below!

***Giveaway***

Enter for a chance to win a Cetaphil Gift Basket!

Fill out the form below to win! There are also several different ways you can get extra entries: sign up for my mailing list, post a link to this giveaway on your blog, follow my blog, follow me & retweet on Twitter , follow me on Pinterest, add me to one of your Google+ circles, follow me on Instagram or become a fan on Facebook. Make sure to list the number of extra entries in the form below. Enter up to once a day to increase your chances of winning!

This giveaway is open to US residents only. The contest will end on Thursday, July 31. I will randomly select a winner and announce them on Lipgloss Break, so keep checking to see if you're a winner - Good Luck!

Note: This post is sponsored by Galderma Laboratories, L.P. Please click here for more information regarding my disclaimer.

Important Safety Information
Indication: Mirvaso^® (brimonidine) topical gel, 0.33% is an alpha adrenergic agonist indicated for the topical treatment of persistent (nontransient) facial erythema of rosacea in adults 18 years of age or older. Adverse Events: In clinical trials, the most common adverse reactions (≥1%) included erythema, flushing, skin burning sensation and contact dermatitis. Warnings/Precautions: Mirvaso Gel should be used with caution in patients with depression, cerebral or coronary insufficiency, Raynaud's phenomenon, orthostatic hypotension, thromboangiitis obliterans, scleroderma, or Sjögren’s syndrome. Alpha-2 adrenergic agents can lower blood pressure. Mirvaso Gel should be used with caution in patients with severe or unstable or uncontrolled cardiovascular disease. Serious adverse reactions following accidental ingestion of Mirvaso Gel by children have been reported. Keep Mirvaso Gel out of reach of children. Not for oral, ophthalmic, or intravaginal use.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

*Each gram of gel contains 5 mg of brimonidine tartrate, equivalent to 3.3 mg of brimonidine free base.

For a long time in my teens, I had issues with extremely red, pink cheeks. My dermatologist at the time finally diagnosed me with rosacea, and I was able to treat it properly. But up until I was diagnosed, I tried multiple brands of cover up and powders to try and disguise it, but really I was just making it worse! I still get flare-ups once in a while, and have to be careful of the products I put on my face.

Here’s a little background on rosacea:

- Rosacea affects an estimated 16 million Americans

- 24% of rosacea sufferers say that persistent redness was their first symptom

- 4 out of 5 rosacea sufferers have used cosmetics to hide their redness (I’m not alone!)

Luckily, there is a treatment to stop concealing, and to start treating! Mirvaso (brimonidine) topical gel, 0.33%* is the only FDA-approved treatment, specifically developed and indicated for the persistent facial redness of rosacea. It can work in as little as 30 minutes! Mirvaso can provide same day results that can last up to 12 hours before the redness returns. I really wish this treatment had been around 15 years ago!

Even if you don’t suffer from rosacea, here are some healthy skincare tips from NYC dermatologist and Clinical Associate Professor New York University Langone Medical Center, Dr. Doris Day:

1 - Calm your skin – Skin with rosacea is more sensitive and likely to react to ingredients in both prescription medications and skin care products, so talk to your dermatologist about what options are best for you. Moisturizers containing lipids, such as ceramides, are usually well tolerated and can improve the skin barrier, which is often compromised in people with this condition.

2 - Be Picky about Sun Protection – It’s a fact that daily sunscreen is a must, but not all sunscreens are created equal. The best bets if you are prone to rosacea, are sunscreens that contain transparent zinc oxide and moisturizing ingredients, like niacinamide, and are fragrance-free and non-comedogenic.

3 - Eat and Sleep Well, Stay Hydrated – It may sound basic, but not getting enough sleep can make you look older because sleep is when your body repairs itself. Alcohol, sugary foods and processed foods can affect the skin’s ability to repair itself and cause premature skin aging, so try to eat a balanced diet and indulge rarely.

For more tips on skincare and to learn more about the treatment of rosacea, check out the Break Up with Your Makeup portal (below). Along with some amazing information, you can also enter for a chance to Win a Trip to the Emmys! Enter by adding your email address below and click ‘Submit.’

Check out the below information and let me know what you think in the comment section. If you have rosacea, how do you manage your redness?

Note: This post is sponsored by Galderma Laboratories, L.P. Please click here for more information regarding my disclaimer.

Important Safety Information
Indication: Mirvaso^® (brimonidine) topical gel, 0.33% is an alpha adrenergic agonist indicated for the topical treatment of persistent (nontransient) facial erythema of rosacea in adults 18 years of age or older. Adverse Events: In clinical trials, the most common adverse reactions (≥1%) included erythema, flushing, skin burning sensation and contact dermatitis. Warnings/Precautions: Mirvaso Gel should be used with caution in patients with depression, cerebral or coronary insufficiency, Raynaud's phenomenon, orthostatic hypotension, thromboangiitis obliterans, scleroderma, or Sjögren’s syndrome. Alpha-2 adrenergic agents can lower blood pressure. Mirvaso Gel should be used with caution in patients with severe or unstable or uncontrolled cardiovascular disease. Serious adverse reactions following accidental ingestion of Mirvaso Gel by children have been reported. Keep Mirvaso Gel out of reach of children. Not for oral, ophthalmic, or intravaginal use.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

*Each gram of gel contains 5 mg of brimonidine tartrate, equivalent to 3.3 mg of brimonidine free base.